Anne Stavelin

521 total citations
34 papers, 335 citations indexed

About

Anne Stavelin is a scholar working on Physiology, Statistics, Probability and Uncertainty and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anne Stavelin has authored 34 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 22 papers in Statistics, Probability and Uncertainty and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anne Stavelin's work include Clinical Laboratory Practices and Quality Control (24 papers), Meta-analysis and systematic reviews (11 papers) and Reliability and Agreement in Measurement (10 papers). Anne Stavelin is often cited by papers focused on Clinical Laboratory Practices and Quality Control (24 papers), Meta-analysis and systematic reviews (11 papers) and Reliability and Agreement in Measurement (10 papers). Anne Stavelin collaborates with scholars based in Norway, United States and United Kingdom. Anne Stavelin's co-authors include Sverre Sandberg, Una Ørvim Sølvik, Per Hyltoft Petersen, Finlay MacKenzie, Piet Meijer, Tony Badrick, Dianne Kitchen, Marc Thelen, Annette Thomas and Patrick J. Twomey and has published in prestigious journals such as Clinical Chemistry, Clinica Chimica Acta and Thrombosis and Haemostasis.

In The Last Decade

Anne Stavelin

30 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Stavelin Norway 13 207 124 66 52 49 34 335
Carmen Biosca Spain 12 444 2.1× 270 2.2× 93 1.4× 27 0.5× 111 2.3× 33 633
Gunn B.B. Kristensen Denmark 11 385 1.9× 225 1.8× 76 1.2× 11 0.2× 28 0.6× 13 500
Francisco A. Bernabéu-Andréu Spain 12 125 0.6× 69 0.6× 40 0.6× 9 0.2× 30 0.6× 31 307
Oswald Sonntag Germany 9 155 0.7× 76 0.6× 36 0.5× 17 0.3× 21 0.4× 33 291
C G Fraser United Kingdom 9 257 1.2× 122 1.0× 53 0.8× 15 0.3× 61 1.2× 16 447
P. W. BARNES United States 7 188 0.9× 40 0.3× 132 2.0× 78 1.5× 12 0.2× 11 498
Ruth O’Kelly Ireland 12 45 0.2× 21 0.2× 90 1.4× 33 0.6× 9 0.2× 20 317
Marta Stahl Denmark 12 152 0.7× 81 0.7× 41 0.6× 20 0.4× 28 0.6× 20 353
Elise Schapkaitz South Africa 10 75 0.4× 15 0.1× 42 0.6× 65 1.3× 12 0.2× 52 319
Lara Milevoj Kopčinović Croatia 12 95 0.5× 33 0.3× 34 0.5× 31 0.6× 7 0.1× 28 301

Countries citing papers authored by Anne Stavelin

Since Specialization
Citations

This map shows the geographic impact of Anne Stavelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Stavelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Stavelin more than expected).

Fields of papers citing papers by Anne Stavelin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Stavelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Stavelin. The network helps show where Anne Stavelin may publish in the future.

Co-authorship network of co-authors of Anne Stavelin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Stavelin. A scholar is included among the top collaborators of Anne Stavelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Stavelin. Anne Stavelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sandberg, Sverre, Thomas Keller, Jeffrey R. Budd, et al.. (2025). Quantification of Difference in Nonselectivity Between In Vitro Diagnostic Medical Devices. Biometrical Journal. 67(1). e70032–e70032. 1 indexed citations
3.
Kitchen, Steve, Erica Scalambrino, Marigrazia Clerici, et al.. (2025). External quality assessment of the manual tilt tube technique for prothrombin time testing: a report from the IFCC-SSC/ISTH Working Group on the Standardization of PT/INR. Clinical Chemistry and Laboratory Medicine (CCLM). 63(7). 1327–1335. 1 indexed citations
5.
Stavelin, Anne, et al.. (2025). Quality assurance using patient split samples: recommendations for primary healthcare laboratories. Clinical Chemistry and Laboratory Medicine (CCLM). 64(1). 147–153.
6.
Hoovels, Lieve Van, Anne Stavelin, Damien Gruson, et al.. (2024). Analytical performance and user-friendliness of four commercially available point-of-care devices for C-reactive protein. Clinica Chimica Acta. 560. 119737–119737. 3 indexed citations
7.
Pendrill, Leslie, Jeanette Melin, Anne Stavelin, & Gunnar Nordin. (2023). Modernising Receiver Operating Characteristic (ROC) Curves. Algorithms. 16(5). 253–253. 8 indexed citations
9.
Stavelin, Anne, Éva Ajzner, Sverre Sandberg, et al.. (2019). Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM). Clinical Chemistry and Laboratory Medicine (CCLM). 57(10). 1511–1521. 9 indexed citations
10.
Stavelin, Anne & Sverre Sandberg. (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 27(1). 81–85. 10 indexed citations
11.
Stavelin, Anne, et al.. (2017). An overview of the European Organization for External Quality Assurance Providers in Laboratory Medicine (EQALM). Biochemia Medica. 27(1). 30–36. 16 indexed citations
12.
Stavelin, Anne, et al.. (2016). The Importance of Reagent Lot Registration in External Quality Assurance/Proficiency Testing Schemes. Clinical Chemistry. 62(5). 708–715. 22 indexed citations
13.
Sølvik, Una Ørvim, et al.. (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 135(9). 849–853. 5 indexed citations
14.
Sølvik, Una Ørvim, et al.. (2014). The influence of coagulation factors on thein-treatmentbiological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 74(6). 470–476. 8 indexed citations
15.
Bolstad, Nils, et al.. (2012). The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients. Scandinavian Journal of Clinical and Laboratory Investigation. 72(5). 374–379. 12 indexed citations
16.
Sølvik, Una Ørvim, et al.. (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine (CCLM). 50(9). 1611–20. 9 indexed citations
17.
Stavelin, Anne, Piet Meijer, Dianne Kitchen, & Sverre Sandberg. (2011). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine (CCLM). 50(1). 81–8. 19 indexed citations
18.
Sølvik, Una Ørvim, et al.. (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 56(10). 1618–1626. 14 indexed citations
19.
Sølvik, Una Ørvim, et al.. (2006). External quality assessment of prothrombin time: The split‐sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 66(4). 337–350. 14 indexed citations
20.
Bolann, Bjørn J., Frank Brosstad, Sverre Sandberg, et al.. (2001). [Analysis of prothrombin time in primary health care].. PubMed. 121(15). 2048–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026